Edition:
India

Elbit Imaging Ltd (EMITF.OQ)

EMITF.OQ on NASDAQ Stock Exchange Global Select Market

1.70USD
2:29am IST
Change (% chg)

$-0.09 (-5.03%)
Prev Close
$1.79
Open
$1.70
Day's High
$1.70
Day's Low
$1.63
Volume
15,482
Avg. Vol
4,544
52-wk High
$3.05
52-wk Low
$1.54

Latest Key Developments (Source: Significant Developments)

Elbit Imaging Announces Update Regarding Agreement To Sell Its Project In Kochi, India
Wednesday, 12 Dec 2018 

Dec 12 (Reuters) - Elbit Imaging Ltd ::ELBIT IMAGING ANNOUNCES UPDATE REGARDING THE AGREEMENT TO SELL ITS PROJECT IN KOCHI, INDIA.ELBIT IMAGING LTD - COMPANY AND INVESTOR HAVE AGREED THAT CONSIDERATION WILL BE PAID IN TWO INSTALLMENTS.ELBIT IMAGING LTD - 50% OF CONSIDERATION WILL BE PAID TO COMPANY UNTIL DECEMBER 31, 2018.ELBIT IMAGING LTD - REMAINING 50% OF CONSIDERATION WILL BE PAID TO COMPANY UNTIL APRIL 30, 2019..  Full Article

Elbit Imaging Settles With Israeli Tax Authority Regarding VAT Assessments
Tuesday, 20 Nov 2018 

Nov 19 (Reuters) - Elbit Imaging Ltd ::ELBIT IMAGING ANNOUNCES SETTLEMENT AGREEMENT WITH ISRAELI TAX AUTHORITY IN REGARDING ITS VAT ASSESSMENTS.ELBIT IMAGING - REACHED AGREEMENT WITH ISRAELI TAX AUTHORITY RELATING TO VAT ASSESSMENTS FOR YEARS 2013-2018.ELBIT IMAGING - WILL PAY ABOUT NIS 5.7 MILLION UNDER AGREEMENT.  Full Article

Elbit Imaging Ltd announces that cms has updated reimbursment code for insightec's mrgfus treatments
Tuesday, 13 Nov 2018 

Nov 13 (Reuters) - Elbit Imaging Ltd ::ELBIT IMAGING LTD. ANNOUNCES THAT CMS HAS UPDATED REIMBURSMENT CODE FOR INSIGHTEC'S MRGFUS TREATMENTS.  Full Article

Elbit Imaging announces update regarding the term sheet to sell the plot in Chennai, India
Wednesday, 7 Nov 2018 

Nov 7 (Reuters) - Elbit Imaging Ltd ::ELBIT IMAGING ANNOUNCES UPDATE REGARDING THE TERM SHEET TO SELL THE PLOT IN CHENNAI, INDIA.ELBIT IMAGING LTD - CLOSING DATE OF TRANSACTION HAS BEEN EXTENDED TO DECEMBER 20, 2018.  Full Article

Elbit Imaging Says Insightec Receives FDA Approval For Exablate Neuro Compatibility
Wednesday, 26 Sep 2018 

Sept 26 (Reuters) - Elbit Imaging Ltd ::ELBIT IMAGING LTD. ANNOUNCES THAT INSIGHTEC RECEIVES FDA APPROVAL FOR EXABLATE NEURO COMPATIBILITY WITH SIEMENS HEALTHINEERS MRI SCANNERS.  Full Article

Elbit Imaging Announces Gamida Cell Appointed New Chairman
Thursday, 20 Sep 2018 

Sept 20 (Reuters) - Elbit Imaging Ltd ::ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL HAS APPOINTED A NEW CHAIRMAN OF THE BOARD.ELBIT IMAGING LTD - ROBERT BLUM CURRENTLY ALSO SERVES AS PRESIDENT AND CEO OF CYTOKINETICS.  Full Article

Elbit Imaging Announces An Updated Evaluation Referring To Elbit Medical Technologies
Thursday, 6 Sep 2018 

Sept 6 (Reuters) - Elbit Imaging Ltd ::ELBIT IMAGING ANNOUNCES AN UPDATED EVALUATION REFERRING TO ELBIT MEDICAL TECHNOLOGIES.ELBIT IMAGING LTD - COMPANY HOLDS ABOUT 89 PCT OF ELBIT MEDICAL'S OUTSTANDING SHARE CAPITAL.  Full Article

Elbit Imaging Says Gamida Cell Pursuing Alternatives For Raising Capital
Friday, 31 Aug 2018 

Aug 31 (Reuters) - Elbit Imaging Ltd ::ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL SUBMITTED CONFIDENTIAL FILINGS AS PART OF PURSUING VARIOUS ALTERNATIVES FOR RAISING CAPITAL.ELBIT IMAGING LTD - GAMIDA CELL LTD PURSUING ALTERNATIVES FOR RAISING ADDITIONAL CAPITAL, INCLUDING IPO OF ITS ORDINARY SHARES IN U.S..ELBIT IMAGING - ELBIT MEDICAL TECHNOLOGIES HOLDS ABOUT 18 PERCENT OF SHARE CAPITAL IN GAMIDA.ELBIT IMAGING LTD - GAMIDA CELL HAS CONFIDENTIALLY SUBMITTED DRAFT FILINGS OF REGISTRATION STATEMENT FOR IPO TO U.S. SEC.  Full Article

Elbit Imaging Enters Into MoU For Sale Of Portion Of Elbit Medical Shares
Thursday, 19 Jul 2018 

July 18 (Reuters) - Elbit Imaging Ltd ::ELBIT IMAGING LTD - ENTERED INTO A NON-BINDING MEMORANDUM OF UNDERSTANDING WITH THE EXIGENT CAPITAL GROUP - SEC FILING.ELBIT IMAGING - NON-BINDING MOU FOR SALE OF BETWEEN 11.6 MILLION AND 115.7 MILLION SHARES OF ELBIT MEDICAL TECHNOLOGIES FOR PRICE PER SHARE OF NIS 0.96.ELBIT IMAGING LTD - ELBIT AND EXIGENT ALSO INTEND TO ENTER INTO A 3-YEAR VOTING AGREEMENT REGARDING APPOINTMENT OF DIRECTORS IN CO.  Full Article

Elbit Imaging Says Gamida Cell Gets Orphan Drug Designation From FDA For Nicord
Tuesday, 17 Jul 2018 

July 17 (Reuters) - Elbit Imaging Ltd ::ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL RECEIVES ORPHAN DRUG DESIGNATION FROM THE FDA FOR NICORD® AS A TREATMENT FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION.ELBIT IMAGING - GAMIDA CELL INFORMED THAT U.S. FDA GRANTED ORPHAN DRUG DESIGNATION FOR NICORD AS TREATMENT FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION.  Full Article

No consensus analysis data available.